Were I managing CytoDyn, I would continue to vigorously market our drug to countries with very outspoken leaders. The Philippines, Brazil and Hungary (under Victor Orban) are obvious choices. Turkey under Erdogon would also be high on my list. I am hoping that promising results in the Philippines will also encourage other SE Asian countries to investigate our drug as well.

Sadly, any strong ally of the US will likely be vulnerable to pressure from our large banks and Big Pharma to avoid even mentioning the name of Leronlimab. The media here, who gets tremendous ad revenue from BP, will likely never cover us until they can’t. As to the FDA, I will not say what I think of them and the “esteemed” Dr. Fauci who are slow rolling an effective drug that has no side effects during an endemic that is killing tens of thousands daily worldwide. They could easily give us an EUA for Covid while continuing a Phase IV trial evaluation to validate our results using proper dosing.

LONG LIVE LERON!